DARMSTADT, Germany, Jan. 20, 2021 /PRNewswire/ -- Not intended for UK-based media Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced an update on the Phase III ...
Researchers retrospectively identified key clinical features and biomarkers of primary immunodeficiency (PID) in pediatric patients with autoimmune cytopenias (AIC) to facilitate early PID diagnosis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results